Xeal Pharma
United Kingdom
About Death Bubba (aka. D Bubba)
DBBIndica HybridDeath Bubba, also known as 'D Bubba', is an indica marijuana strain bred by Matteo Suleyman of Sea to Sky Cannabis in Vancouver, BC, Canada.
Bred by 
Sea to Sky
This strain is a 70%-30% Indica dominant cross between Death-Star & Bubba Kush, both top quality strains. This strain is famous for it's very potent kush aroma and taste, both earthy and sour and with a THC content around 24-27% it can really pack a punch.
This is a Canadian created strain by a Matteo Suleyman from Sea to Sky in Vancouver, BC.
Description provided by Seedfinder.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About 4C Labs Ltd.
We are a vertically-integrated medical cannabis cultivator and digital healthcare provider. A holistic solution and platform that makes medical cannabis more accessible.
Moving forward with a value-driven strategy. The 4C name was conceived from a value-first approach for our patients and doctors – which is why Care, Commitment, Choice and Change are more than just concepts to us; they are the very foundation on which our company was built.
This is reflected in the team that we have spent the last several years assembling that spans compliance, cultivation, technology, engineering and healthcare. A team with the sole focus of revolutionising medical cannabis for both patients and doctors in the UK.
UK patients deserve access to medicines that have been tested, certified and grown organically using proven cannabis genetics. With a deep understanding of plant genetics and innovative dosing strategies, 4C Labs delivers custom tailored solutions to address patients’ specific needs.
4C Labs’ cultivation strategy is spear-headed by a Canadian Master Grower with 25+ years experience supplying sought after products to compassion centres that serve the cancer community and others who suffer from chronic illnesses.
We are primed to scale with the market and have considerably lower set-up costs when compared to many other cannabis companies.
Our state of the art data analytics platform (under development) is set up to deliver insights to our R&D Team that will lead to innovative solutions to common global human health issues.
4clabs.co
Further National Health-Service Information on